Tae Wook Oh, an attorney at Kim & Chang, practices in corporate criminal/white collar crime, pharmaceutical/medical devices regulation advice and investigation response, compliance consulting, anti-corruption/compliance management, corporate internal investigation, and regulatory investigation and litigation response, etc. With his expertise and career in various industries, and in-depth understanding in digital forensic and electronic evidence, Mr. Oh has established and provided effective response strategies for clients in investigation and litigation procedures.
Mr. Oh particularly has demonstrated his expertise in investigation and trial response, which has been proven by his outstanding performance in responding to search and seizure, investigation and warrant validity investigation, etc. He also has shown excellent results in a broad spectrum of cases covering the Pharmaceutical Affairs Act, the Medical Devices Act, the Financial Investment Services and Capital Markets Act, the Act on External Audit of Stock Companies, industrial/serious accidents, the Foreign Exchange Transactions Act, the Customs Act, and the Unfair Competition Prevention and Trade Secret Protection Act, where he efficiently established response strategies and effectively implemented action plans.
Further, Mr. Oh has provided legal advisory services on various issues related to rebate, fair trade and advertising to numerous clients in the healthcare industry, including pharmaceutical and medical device businesses. He has drawn successful outcomes for global enterprises in civil, criminal and administrative stages, and also established monitoring systems for compliance management in the projects of large corporate groups for their compliance enhancement. In particular, he has conducted in-depth research and inspection on various customers in and outside Korea, to analyze their problems and come up with solutions. With his systematic support throughout each and every step, he has consistently assisted clients’ ceaseless innovation and sustainable growth.
